This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,739.04, is for the delivery of Entecavir 0.5mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $9,458.03 firm fixed-price delivery order is for the supply of 4,565,749,496 tablets of the medication Entecavir 0.5 mg. The contract has an ultimate completion date of September 11, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous contracts by the DLA and other federal agencies to provide a wide range of...
This federal contract award, with ID SPE2DB20D3103|SPE2DB23FN0X7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,181.47 firm fixed-price delivery order is for the supply of Entecavir 1 mg tablets. This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,269.85, is for the delivery of the prescription medication Entecavir 0.5 mg tablet. This is a firm fixed-price delivery order contract with an ultimate completion date of September 28, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award was issued by the Medical Supply Chain unit of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $10,669.80 firm fixed-price delivery order is for the supply of 4,565,297 units of Entecavir 0.5 mg tablets. The contract has a final delivery date of July 31, 2024 and does not have a set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous indefinite delivery contracts by...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,758.86 Firm Fixed Price Delivery Order is for the supply of 4564950562 - Entecavir 0.5 mg Tablet 30s, with a period of performance through June 21, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
This federal contract award, valued at $3,422.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Entecavir 0.5 mg tablets and has a performance period through January 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,287.52 firm fixed-price delivery order is for the supply of ENTECAVIR 0.5 MG TABLET 30S, a medication used to treat chronic hepatitis B. The award has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Entecavir 0.5 mg tablets. The contract has a potential value of $5,038.26 and a completion date of January 5, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical products and medical...
This federal contract award, valued at $2,099.05, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract provides for the delivery of ENTECAVIR 0.5 MG TABLET 30S, a pharmaceutical product, with a performance period ending on March 26, 2025. This award is a Delivery Order contract with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...